Cargando…
Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease and bronchiolitis in children, as well as an important cause of morbidity and mortality in elderly and immunocompromised individuals. However, there is no safe and efficacious RSV vaccine or antiviral treatment....
Autores principales: | Salinas, Franco Maximiliano, Nebreda, Antonela Díaz, Vázquez, Luciana, Gentilini, María Virginia, Marini, Victoria, Benedetti, Martina, Nabaes Jodar, Mercedes Soledad, Viegas, Mariana, Shayo, Carina, Bueno, Carlos Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202858/ https://www.ncbi.nlm.nih.gov/pubmed/32387475 http://dx.doi.org/10.1016/j.antiviral.2020.104817 |
Ejemplares similares
-
RSV reemergence in Argentina since the SARS-CoV-2 pandemic
por: Dolores, Acuña, et al.
Publicado: (2022) -
Respiratory Syncytial Virus (RSV)
por: Walsh, Edward E., et al.
Publicado: (2015) -
Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020) -
Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022) -
Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis
por: Chee, Chris, et al.
Publicado: (2010)